Advances in the Research of Human Soluble Epoxide Hydrolase Inhibitors

doi:10.6023/cjoc1107132

Abstract

Hypertension is a common illness nowadays. Although a wide variety of antihypertensive agents are available in the market for the treatment of hypertension, the antihypertensive treatment tends to be individualized, and the treatment should exceed the limitation of lowering blood pressure only. Compared to other antihypertensive agents, the advantage of human soluble epoxide hydrolase inhibitors (HsEHIs) is that they can not only reduce the blood pressure, but also have remarkable anti-inflammatory effects. Herein, the development of human soluble epoxide hydrolase inhibitors is reviewed from early epoxide HsEHIs to the third generation of urea HsEHIs.

Key words: soluble epoxide hydrolase, epoxyeicosatrienoic acid, inhibitors, 1,3-disubstituted urea, hypertension, inflammation

Cite this article

Huang Shaoxu, Wang Yong, Long Yaqiu. Advances in the Research of Human Soluble Epoxide Hydrolase Inhibitors[J]. Chin. J. Org. Chem., 2012, 32(05): 877-888.

Export EndNote|Reference Manager|ProCite|BibTeX|RefWorks

share this article

References

[1] Jerina, D. M. Lloydia 1974, 37, 212.

[2] Oliw, E. H. Prog. Lipid Res. 1994, 33, 329.

[3] Morisseau, C. Hammock, B. D. Annu. Rev. Pharmacol. Toxicol.2005, 45, 311.

[4] Hammock, B. D.; Grant, D.; Storms, D. In Comprehensive Toxicology,Eds.: Sipes, I.; McQueen, C.; Gandolfi, A., Pergamon, NewYork, 1997, 283.

[5] Oesch, F. Xenobiotica 1973, 3, 305.

[6] Levin, W.; Michaud, D. P.; Thomas, P. E.; Jerina, D. M. Arch.Biochem. Biophys. 1983, 220, 485.

[7] Pace-Asciak, C. R.; Lee, W. S. J. Biol. Chem. 1989, 264, 9310.

[8] (a) Yu, Z.; Xu, F.; Huse, L. M.; Morisseau, C.; Draper, A. J. Circ.Res. 2000, 87, 992.(b) Davis, B. B.; Thompson, D. A.; Howard, L. L.; Morisseau, C.;Hammock, B. D. Proc. Natl. Acad. Sci U. S. A. 2002, 99, 2222.(c) Imig, J. D.; Zhao, X.; Capdevila, J. H.; Morisseau, C.; Hammock,B. D. Hypertension 2002, 39, 690.(d) Zhao, X.; Yamamoto, T.; Newman, J. W.; Kim, I. H.; Watanabe,T. J. Am. Soc. Nephrol. 2004, 15, 1244.

[9] Arand, M.; Grant, D. F.; Beetham, J. K.; Friedberg, T.; Oesch, F.;Hammock, B. D. FEBS Lett. 1994, 338, 251.

[10] Ollis, D. L.; Cheah, E.; Cygler, M.; Dijkstra, B.; Frolow, F. Curr.Protein Pept. Sci. 2000, 1, 209.

[11] Moghaddam, M. F.; Grant, D. F.; Cheek, J. M.; Greene, J. F.; Williamson,K. C.; Hammock, B. D. Nat. Med. 1997, 3, 562.

[12] Morisseau, C.; Goodrow, M. H.; Dowdy, D.; Zheng, J.; Greene, J.F.; Sanborn, J. R.; Hammock, B. D. Proc. Natl. Acad. Sci. U. S. A.1999, 96, 8849.

[13] Spector, A. A.; Fang, X.; Snyder, G. D.; Weintraub, N. L. Prog.Lipid Res. 2004, 43, 55.

[14] (a) Imig, J. D.; Zhao, X.; Zaharis, C. Z.; Olearczyk, J. J.; Pollock,D. M.; Newman, J. W.; Kim, I.-H.; Watanabe, T.; Hammock, B. D.Hypertension 2005, 46, 975.(b) Ai, D.; Fu, Y.; Guo, D.; Tanaka, H.; Wang, N.; Tang, C.;Hammock, B. D.; Shyy, J. Y.-J.; Zhu, Y. Proc. Natl. Acad. Sci. U.S. A. 2007, 104, 9018.

[15] Sinal, C. J.; Miyata, M.; Tohkin, M.; Nagata, K.; Bend, J. R.; Gonzalez,F. J. J. Biol. Chem. 2000, 275, 40504.

[16] Kim, I.-H.; Nishi, K.; Tsai, H.-J.; Bradford, T.; Koda, Y.; Watanabe,T.; Morisseau, C.; Blanchfield, J.; Tothb, I.; Hammock, B. D.Bioorg. Med. Chem. 2007, 15, 312.

[17] The ALLHAT Officers and Coordinators for the ALLHAT CollaborativeResearch Group J. Am. Med. Assoc. 2002, 288, 2981.

[18] Schmelzer, K. R.; Inceoglu, B.; Kubala, L.; Kim, I. H.; Jinks, S. L.;Eiserich, J. P.; Hammock, B. D. Proc. Natl. Acad. Sci. U. S. A.2006, 103, 13646.

[19] Mullin, C. A.; Hammock, B. D. 1982, 216, 423.

[20] Dietze, E. C.; Kuwano, E.; Casas, J.; Hammock, B. D. Biochem.Pharmacol. 1991, 42, 1163.

[21] Morisseau, C.; Du, G.; Newman, J. W.; Hammock, B. D. Arch.Biochem. Biophys. 1998, 356, 214.

[22] Draper, A. J.; Hammock, B. D. Toxicol. Sci. 1999, 52, 26.

[23] Gaetke, L. M.; McClain, C. J.; Talwalkar, R. T.; Shedlofsky, S. I.Am. J. Physiol. Endocrin. Metab. 1997, 272, E952.

[24] Dietze, E. C.; Kuwano, E.; Hammock, B. D. Anal. Biochem. 1994,216, 176.

[25] Jones, P. D.; Wolf, N. M.; Morisseau, C.; Whetstone, P.; Hock, B.;Hammock, B. D. Anal. Biochem. 2005, 343, 66.

[26] Argiriadi, M. A.; Morisseau, C.; Hammock, B. D.; Christianson, D.W. Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 10637. [27] Morisseaua, C.; Goodrow, M. H.; Newman, J. W.; Wheelock, C.E.; Dowdy, D. L.; Hammock, B. D. Biochem. Pharmacol. 2002, 63,1599.

[28] Kim, I.-H.; Morisseau, C.; Watanabe, T.; Hammock, B. D. J. Med.Chem. 2004, 47, 2110.

[29] Kim, I.-H.; Heirtzler, F. R.; Morisseau, C.; Nishi, K.; Tsai, H.-J.;Hammock, B. D. J. Med. Chem. 2005, 48, 3621.

[30] (a) Argiriadi, M. A.; Morisseau, C.; Goodrow, M. H.; Dowdy, D.L.; Hammock, B. D.; Christianson, D. W. J. Biol. Chem. 2000, 275,15265.(b) Gomez, G. A.; Morisseau, C.; Hammock, B. D.; Christianson,D. W. Biochemistry 2004, 43, 4716.

[31] Morisseau, C.; Newman, J. W.; Tsai, H.-J.; Baecker P. A.; Hammock,B. D. Bioorg. Med. Chem. Lett. 2006, 16, 5439.

[32] Jones, P. D.; Tsai, H.-J.; Do, Z. N.; Morisseau, C.; Hammock, B. D.Bioorg. Med. Chem. Lett. 2006, 16, 5212.

[33] Li, H.-Y.; Jin, Y.; Morisseau, C.; Bruce, D.; Hammock, B. D.;Long, Y.-Q. Bioorg. Med. Chem. 2006, 14, 6586.

[34] Huang, S.-X.; Li, H.-Y.; Liu, J.-Y.; Morisseau, C.; Hammock, B.D.; Long, Y.-Q. J. Med. Chem. 2010, 53, 8376.

[35] Kasagami, T.; Kim, I.-H.; Tsai, H.-J.; Nishi, K.; Hammock, B. D.;Morisseau, C. Bioorg. Med. Chem. Lett. 2009, 19, 1784.

[36] Anandan, S.-K.; Webb, H. K.; Do, Z. N.; Gless, R. D. Bioorg. Med.Chem. Lett. 2009, 19, 4259.

[37] Rose, T. E.; Morisseau, C.; Liu, J.-Y.; Inceoglu, B.; Jones, P. D.;Sanborn, J. R.; Hammock, B. D. J. Med. Chem. 2010, 53, 7067.

[38] Eldrup, A. B.; Soleymanzadeh, F.; Farrow, N. A.; Kukulka, A.; DeLombaert, S. Bioorg. Med. Chem. Lett. 2010, 20, 571.

[39] Kim, I.-H.; Park, Y.-K.; Hammock, B. D.; Nishi, K. J. Med. Chem.2011, 54, 1752.

[40] Xie, Y.; Liu, Y.; Gong, G.; Smith, D. H.; Yan, F.; Rinderspacher,A.; Feng, Y.; Zhu, Z.; Li X.; Deng, S.-X.; Branden, L.; Vidovi?, D.;Chung, C.; Sch黵er, S.; Morisseau, C.; Hammock, B. D.; Landry,D. W. Bioorg. Med. Chem. Lett. 2009, 19, 2354.

[41] Taylor, S. J.; Soleymanzadeh, F.; Eldrup, A. B.; Farrow, N. A.;Muegge, I.; Kukulka, A.; Kabcenell, A. K.; De Lombaert, S. Bioorg.Med. Chem. Lett. 2009, 19, 5864.

[42] Eldrup, A. B.; Soleymanzadeh, F.; Taylor, S. J.; Muegge, I.;Farrow, N. A.; Joseph, D.; McKellop, K.; Man, C. C.; Kukulka, A.;De Lombaert, S. J. Med. Chem. 2009, 52, 5880.

[43] (a) Shen, H. C.; Ding, F.-X.; Wang, S.; Deng, Q.; Zhang, X.; Chen,Y.; Zhou, G.; Xu, S.; Chen, H.-S.; Tong, X.; Tong, V.; Mitra, K.;Kumar, S.; Tsai, C.; Stevenson, A. S.; Pai, L.-Y.; Alonso-Galicia,M.; Chen, X.; Soisson, S. M.; Roy, S.; Zhang, B.; Tata, J. R.; Berger,J. P.; Colletti, S. L. J. Med. Chem. 2009, 52, 5009.(b) Shen, H. C.; Ding, F.-X.; Wang, S.; Xu, S.; Chen, H.-S.; Tong,X.; Tong, V.; Mitra, K.; Kumar, S.; Zhang, X.; Chen, Y.; Zhou, G.;Pai, L.-Y.; Alonso-Galicia, M.; Chen, X.; Zhang, B.; Tata, J. R.;Berger, J. P.; Colletti, S. L. Bioorg. Med. Chem. Lett. 2009, 19,3398.(c) Shen, H. C.; Ding, F.-X.; Deng, Q.; Xu, S.; Tong, X.; Zhang,X.; Chen, Y.; Zhou, G.; Pai, L.-Y.; Alonso-Galicia, M.; Roy, S.;Zhang, B.; Tata, J. R.; Berger, J. P.; Colletti, S. L. Bioorg. Med.Chem. Lett. 2009, 19, 5716.(d) Shen, H. C.; Ding, F.-X.; Deng, Q.; Xu, S.; Chen, H.-S.; Tong,X.; Tong, V.; Zhang, X.; Chen, Y.; Zhou, G.; Pai, L.-Y.;Alonso-Galicia, M.; Zhang, B.; Roy, S.; Tata, J. R.; Berger, J. P.;Colletti, S. L. Bioor. Med. Chem. Lett. 2009, 19, 5314.

[44] Xing, L.; McDonald, J. J.; Kolodziej, S. A.; Kurumbail, R. G.; Williams,J. M.; Warren, C. J.; O'Neal, J. M.; Skepner, J. E.; Roberds,S. L. J. Med. Chem. 2011, 54, 1211.

[45] Tanaka, D.; Tsuda, Y.; Shiyama, T.; Nishimura, T.; Chiyo, N.; Tominaga,Y.; Sawada, N.; Mimoto, T.; Kusunose, N. J. Med. Chem.2011, 54, 851.

人类可溶性环氧化物水解酶抑制剂的研究进展